1. Home
  2. Live Updates
  3. FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara (Ustekinumab) : vimarsana.com

FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara (Ustekinumab) : vimarsana.com

FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara (Ustekinumab)

FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara (Ustekinumab)

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , United Kingdom , United States , Seika Pharma , Intas Pharmaceuticals , Drug Administration , Accord Biopharma Inc , Janssen Biotech Inc , Intas Pharmaceuticals Ltd , Donga Socio Holdings , Accord Healthcare Ltd , Accord Biopharma , Biologics License Application , Marketing Authorization Application , Accord Healthcare , Socio Holdings , Meiji Seika Pharma , Chong Park , Hee Park ,